Skip to main content

Table 3 Monte Carlo dose calculation: accumulated dose-volume characteristics for the CTV and organs at risk. Each row indicates data from a separate patient

From: Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial

CTV D95 without / with electrodes

CTV EUD without / with electrodes

Accumulated min surface dose to the hottest 1 cm2 in shells up to 2, 4, 6, 8, 10 mm without electrodes

Accumulated min surface dose to the hottest 1 cm2 in shells up to 2, 4, 6, 8, 10 mm with electrodes

D2 Brain - PTV without / with electrodes

101.6 / 100.6

103.7 / 102.4

67.8 / 80.3 / 89.1 / 96.6 / 102.8

75.3 / 86.6 / 86.3 / 86.3 / 104.4

84.1 / 83.1

98.9 / 97.9

102.1 / 101.1

87.5 / 101.7 / 106.9 / 107.5 / 107.0

93.4 / 102.4 / 107.1 /107.0 /105.9

89.3 / 88.2

95.0 / 93.7

98.1 / 97.5

93.5 / 97.4 / 99.6 / 98.9 / 100.5

98.1 / 102.0 / 106.2 / 106.8 / 105.8

94.8 / 93.8

96.3 / 95.8

101.0 / 100.3

93.5 / 103.6/ 101.5 / 101.5 / 105.4

99.0 / 110.0 / 101.5 / 109.5 / 109.9

93.0 / 92.3

97.8 / 97.5

100.6 / 100.0

80.3 / 101.3 / 107.6 / 109.2 / 109.1

87.0 / 101.5 / 107.2 / 108.0 / 107.4

74.9 / 74.5

99.4 / 98.9

102.4 / 101.5

96.6 / 102.9 / 104.3 / 104.9 / 106.3

100.3 / 106.8 / 110.0 / 110.3 / 110.8

99.4 / 98.8

100.0 / 99.2

101.8 / 100.8

82.7 / 97.7 / 98.7 / 99.2 / 99.8

89.2 / 105.6 / 109.9 / 108.3 / 107.8

87.3 /86.4

  1. Note: doses are given as relative doses normalized to the prescribed dose; four adjacent scalp+calvaria shells were defined as tissue slices of 2 mm thickness below the surface of the scalp in a depth of 0–2 mm, 2–4 mm, 4–6 mm, 6–8 mm, and 8-10 mm